These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32941420)

  • 21. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
    Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of antibiotic combination therapy as evaluated by the Break-point Checkerboard Plate method for multidrug-resistant Pseudomonas aeruginosa in clinical use.
    Nakamura I; Yamaguchi T; Tsukimori A; Sato A; Fukushima S; Mizuno Y; Matsumoto T
    J Infect Chemother; 2014 Apr; 20(4):266-9. PubMed ID: 24486172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
    Wootton M; Walsh TR; Macfarlane L; Howe RA
    J Antimicrob Chemother; 2010 Jan; 65(1):79-81. PubMed ID: 19915068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E; Zer Y; Eksi F
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.
    Montero MM; Domene Ochoa S; López-Causapé C; VanScoy B; Luque S; Sorlí L; Campillo N; Padilla E; Prim N; Segura C; Pomar V; Rivera A; Grau S; Ambrose PG; Oliver A; Horcajada JP
    J Glob Antimicrob Resist; 2019 Sep; 18():37-44. PubMed ID: 31154007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach.
    Di Bonaventura G; Picciani C; Spedicato I; Piccolomini R
    New Microbiol; 2004 Jul; 27(3):263-72. PubMed ID: 15460529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread.
    Poulsen HO; Johansson A; Granholm S; Kahlmeter G; Sundqvist M
    J Antimicrob Chemother; 2013 Sep; 68(9):1974-7. PubMed ID: 23640126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.
    Hillier S; Roberts Z; Dunstan F; Butler C; Howard A; Palmer S
    J Antimicrob Chemother; 2007 Jul; 60(1):92-9. PubMed ID: 17540675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of
    Betts JW; Hornsey M; Higgins PG; Lucassen K; Wille J; Salguero FJ; Seifert H; La Ragione RM
    J Med Microbiol; 2019 Oct; 68(10):1552-1559. PubMed ID: 31419210
    [No Abstract]   [Full Text] [Related]  

  • 31. Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli.
    Podnecky NL; Fredheim EGA; Kloos J; Sørum V; Primicerio R; Roberts AP; Rozen DE; Samuelsen Ø; Johnsen PJ
    Nat Commun; 2018 Sep; 9(1):3673. PubMed ID: 30202004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

  • 33. Occurrence and antibacterial susceptibility pattern of bacterial pathogens isolated from diarrheal patients in Pakistan.
    Rasool MH; Siddique AB; Saqalein M; Asghar MJ; Zahoor MA; Aslam B; Shafiq HB; Nisar MA
    Saudi Med J; 2016 Mar; 37(3):274-9. PubMed ID: 26905349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro assessment of the antibacterial effects of the combinations of fosfomycin, colistin, trimethoprim and nitrofurantoin against multi-drug-resistant Escherichia coli.
    Mohamed Abu El-Wafa W; Abouwarda AM
    Lett Appl Microbiol; 2022 Mar; 74(3):334-343. PubMed ID: 34839528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation by Monte Carlo simulation of levofloxacin dosing for complicated urinary tract infections caused by Escherichia coli or Pseudomonas aeruginosa.
    Deguchi T; Seike K; Yasuda M; Matsumoto T
    J Infect Chemother; 2011 Oct; 17(5):726-30. PubMed ID: 21409530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
    Richards RM; Hamilton VE; Thomas MR
    J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department.
    Filiatrault L; McKay RM; Patrick DM; Roscoe DL; Quan G; Brubacher J; Collins KM
    CJEM; 2012 Sep; 14(5):295-305. PubMed ID: 22967697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vitro evaluation of antibiotic combinations for urinary tract infections in patients with diabetes mellitus.
    Menon BB; Pathare NA
    Indian J Pathol Microbiol; 2004 Oct; 47(4):565-8. PubMed ID: 16295399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of plumbagin with five common antibiotics against Staphylococcus aureus in vitro.
    Bie S; Mo Q; Shi C; Yuan H; Li C; Wu T; Li W; Yu H
    PLoS One; 2024; 19(1):e0297493. PubMed ID: 38277418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.